COVID-19

Ebola Ebola virus Ebolavirus outbreak
Pharma

Merck eyes COVID antiviral Lagevrio amid Ebola outbreak

Merck & Co. is considering dusting off its antiviral molnupiravir, previously authorized as a COVID-19 treatment, to meet the current Ebola outbreak.
Fraiser Kansteiner Jun 2, 2026 10:40am
Xocova COVID-19

Shionogi's Japan-approved antiviral nets US COVID nod

Jun 1, 2026 11:11am
Medical staff with blue gloves and protective equipment removing box of vaccines in storage of the freezer

FDA blocks publication of vaccine safety studies: NYT

May 6, 2026 11:20am
Pfizer

Pfizer's COVID franchise keeps guidance level after strong Q1

May 5, 2026 11:17am
Sanofi

Sanofi's new COVID shot tops Moderna's mNexspike in safety trial

Apr 20, 2026 10:52am
skiing snow fresh tracks path ski mountains hill ride powder fresh

Invivyd launches new antibody campaign with skier Lindsey Vonn

Apr 8, 2026 8:58am
More News

Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals

Apr 6, 2026 8:37am

BioNTech to turn out the lights at Singapore vaccine facility

Apr 2, 2026 2:51pm

Poland, Romania ordered to pay $2.2B in Pfizer COVID vax suit

Apr 2, 2026 11:56am

Moderna CEO pay hits $19.9M as cost cuts boost cash bonus

Mar 17, 2026 12:10pm